Status:
COMPLETED
A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
40-80 years
Phase:
PHASE1
Brief Summary
This 4 arm study will investigate the pharmacodynamics and pharmacokinetics of RO4998452 in type 2 diabetes patients with varying degrees of renal impairment. Eligible patients will be divided into 4 ...
Eligibility Criteria
Inclusion
- adult patients, 40-80 years of age;
- type 2 diabetes;
- normal renal function, or impaired but stable renal function;
- stable with regard to medication or treatment regimen taken for renal impairment or diabetes.
Exclusion
- patients with a renal transplant;
- end-stage renal disease, requiring dialysis;
- nephrotic syndrome, or a history of nephrectomy;
- type 1 diabetes mellitus.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00933972
Start Date
June 1 2009
End Date
September 1 2010
Last Update
November 2 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Renton, Washington, United States, 98055
2
Moscow, Russia, 115419